Skip to content

The effect of N- acethylcystein on pain treatment

The effect of N-acethylcystein on pain after laparascopic cholecystectomy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014112120020N1
Enrollment
30
Registered
2015-10-28
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain after laparascopic cholecystectomy. calculus of gallbladder without cholecystitis

Interventions

Intervention 1: The night before surgery, 1200mg oral N-acethylcysteine in the form of two effervescent tablets (600mg)dissolved in water were given to the intervention group and the morning before o
Treatment - Drugs
The night before surgery, 1200mg oral N-acethylcysteine in the form of two effervescent tablets (600mg)dissolved in water were given to the intervention group and the morning before operation, 3cc of
For the control group, two vit c effervescent tablets (placebo) dissolved in water, were given at night before surgery and 3cc distilled water in 100cc normal saline as placebo transfused in 5 minutes

Sponsors

Vice chancellor for research, Babol University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 20-50 years old; candidate for laparascopic cholecystectomy; ASA class1(healthy patient without other disease). Exclusion criteria: previous abdominal surgery; known sensitivity to N- acethylcystein; operation time more than 2 hours; any uncommon complication in operation or in intubation; chronic pain before operation; neuropsychiatric disease; addiction; pregnancy; lactation and other concurrent surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: in recovery and 1, 2, 4, 8, 12 and 24 hours after operation. Method of measurement: visual analog scale(VAS).

Secondary

MeasureTime frame
Nausea and vomiting. Timepoint: In recovery and 1, 2, 4, 8, 12 and 24 hour after operation. Method of measurement: scale 0-4.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMrs Sedighe Soleimanian

Babol Universityof Medical Science

dr.m.ebrahhmzade@gmail.com+98 11 3223 8301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026